News ArchivesRead News
Writing Can Diagnose Parkinson's
Wednesday October 30, 2013
Abigail Klein Leichman
Jewish Journal - A new Israeli study comparing the handwriting of healthy people to those with Parkinson’s disease holds out the promise of providing a simple diagnostic tool at the earliest stages of the progressive disorder caused by the death of nerve cells in the brain’s muscle-movement control areas.
As many as 10 million people worldwide suffer the tremors, impaired balance and rigidity associated with Parkinson’s, which has no cure. In the United States, about 60,000 Americans are diagnosed with the disease each year, according to the Parkinson’s Disease Foundation.
The handwriting study is the latest of many Israeli investigations into Parkinson’s. Unfortunately, physicians can diagnose the disease definitively only by observing clinical symptoms that appear at a relatively advanced stage, or by administering a test called SPECT, which uses radioactive material to image the brain.
But researchers at the University of Haifa and Rambam Medical Center in Haifa believe their study shows how the disease can be detected sooner, noninvasively and without radiation.
“Identifying the changes in handwriting could lead to an early diagnosis of the illness and neurological intervention at a critical moment,” explained Sara Rosenblum of the university’s department of occupational therapy.
She said that publication of results in the journal of the European Neurological Society aroused great interest at the International Congress of Parkinson’s Disease and Movement Disorders held last summer in Sydney, Australia.
Rosenblum initiated the study, which compared handwriting samples from 40 subjects, some of whom had Parkinson’s and some of whom were disease-free. She was building on previous research that has shown unique and distinctive differences between the handwriting of Parkinson’s patients and that of healthy people. However, most of those studies focused on motor skills (drawing spirals, for instance) and not on writing that involves cognitive abilities, such as signing a check or copying addresses.
According to Rosenblum, Parkinson’s patients notice a change in their cognitive abilities even before they experience a change in their motor abilities.
Her handwriting research was conducted in cooperation with Dr. Ilana Schlesinger, head of the Center for Movement Disorders and Parkinson’s Disease at Rambam, and occupational therapists at the hospital.
Half of the 40 participants were known to be in the early stages of Parkinson’s disease, before obvious motor signs are visible. The subjects were instructed to write their names and to copy addresses — two everyday tasks that require cognitive abilities.
The writing was done on a regular piece of paper placed on an electronic tablet, using a special pen with pressure-sensitive sensors. A computerized analysis of the results compared writing form (length, width and height of the letters), time required and the pressure exerted on the surface while performing the assignment.
There were significant differences between the Parkinson’s patients and the healthy group, and all subjects, except one, had their status correctly diagnosed (97.5 percent accuracy).
The Parkinson’s disease patients wrote their letters smaller, exerted less pressure on the writing surface and took more time to complete the task. Rosenblum said the most striking difference was the length of time the pen was in the air between the writing of each letter and each word.
“This finding is particularly important because while the patient holds the pen in the air, his mind is planning his next action in the writing process, and the need for more time reflects the subject’s reduced cognitive ability,” she said. “Changes in handwriting can occur years before a clinical diagnosis and therefore can be an early signal of the approaching disease.”
Validating these findings in a broader study could pave the way for this method to be used for a preliminary diagnosis of the disease in a safe and non-invasive fashion.
“This study is a breakthrough toward an objective diagnosis of the disease,” said Schlesinger, noting that this method would reduce the load on the health system because the test can be performed by a professional other than a doctor.
The researchers are currently applying the same method in a new experiment, using handwriting analysis to evaluate the degree of functional improvement in Parkinson’s patients who have received brain-implanted pacemakers.
Leichman, A.K. (13 Oct. 2013). Jewish Journal. Writing Can Diagnose Parkinson's. www.jewishjournal.com
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show